Furthermore, signaling pathways at AD onset that were primarily addressed with CBD treatment (e.g., embryonic stem cell pluripotency, adipogenesis, proliferation and myelination, and molecular mechanisms of cancer) centered on Smad9. The gene discussed is SMAD9; the disease is cancer.